HORN Pharmaceutical Consulting is a consulting firm specializing in regulatory and business advice for the pharmaceutical, biotechnology, and medical device industries. Founded in 2002, the company offers a wide range of global consulting services, including support for product development, clinical trials, and marketing authorization applications. With a slogan emphasizing "Quality that matters!" the company focuses on delivering high-value consulting services to clients in the Pharma and Biotech Industry, both in the EU and US.
The firm's core industries include biotechnology and pharmaceuticals, positioning it as a crucial player in the life sciences sector. While specific headquarter location and the details of the last investment remain undisclosed, HORN Pharmaceutical Consulting's expertise and industry focus make it an attractive prospect for potential investors looking to capitalize on the growth of the pharmaceutical and biotech sectors. Its established track record and focus on quality make it a compelling option for those seeking investment opportunities in these industries.